chemotherapy

Test May Identify Poor Prognosis for Some Patients with Lung Cancer

Wednesday, September 16, 2015

Reblogged from the NCI Cancer Currents Blog. Original posted July 13, 2015.

A panel of three genetic markers may help to identify patients with early-stage lung cancer who have a very strong likelihood of their disease returning after surgery, according to findings from a study by NCI researchers.

A panel of genetic markers may identify patients with stage I lung cancer with a poor prognosis, suggesting that they may benefit from post-surgical chemotherapy.

Cancer Prevention Versus Cure? One Physician-Scientist's "Pet Peeve"

Friday, February 27, 2015

“Then we have ‘prevention is more important than cure.’ That’s the one I like best. That’s my pet peeve…."

Dr. Emil Freireich, NCI, in his 1997 oral history. Dr. Freireich helped develop combined chemotherapy for childhood leukemia.